BRAF mutations may affect the antigen-processing and -presentation mechanisms of tumor cells, reducing the expression of major histocompatibility complex molecules and weakening the ability of tumor cells to be recognized by the immune system. The gene discussed is BRAF; the disease is neoplasm.